Pascal Girard

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Machine Learning

Tyrosine Kinase

Metastatic Colorectal Cancer

Positron Emission Tomography

Top Venues

Cancer chemotherapy and pharmacology

JCO clinical cancer informatics

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ana-Marija Milenković-Grišić, Siobhán Hayes, Colm Farrell, Yoshihiro Kuroki, Mauro Bertolino, Karthik Venkatakrishnan, Pascal Girard
Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer. Clinical pharmacology and therapeutics (2024)
Daniel Abler, Perrine Courlet, Matthieu Dietz, Roberto Gatta, Pascal Girard, Alain Munafo, Alexandre Wicky, Mario Jreige, Monia Guidi, Sofiya Latifyan, Rita De Micheli, Chantal Csajka, John O Prior, Olivier Michielin, Nadia Terranova, Michel A Cuendet
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging. JCO clinical cancer informatics 7 (2023)
Daniel Abler, Perrine Courlet, Matthieu Dietz, Roberto Gatta, Pascal Girard, Alain Munafo, Alexandre Wicky, Mario Jreige, Monia Guidi, Sofiya Latifyan, Rita De Micheli, Chantal Csajka, John O Prior, Olivier Michielin, Nadia Terranova, Michel A Cuendet
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging. JCO clinical cancer informatics 7 (2023)
Perrine Courlet, Daniel Abler, Monia Guidi, Pascal Girard, Federico Amato, Naik Vietti Violi, Matthieu Dietz, Nicolas Guignard, Alexandre Wicky, Sofiya Latifyan, Rita De Micheli, Mario Jreige, Clarisse Dromain, Chantal Csajka, John O Prior, Karthik Venkatakrishnan, Olivier Michielin, Michel A Cuendet, Nadia Terranova
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy. CPT: pharmacometrics & systems pharmacology (2023)
Wenyuan Xiong, Orestis Papasouliotis, E Niclas Jonsson, Rainer Strotmann, Pascal Girard
Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study. Cancer chemotherapy and pharmacology 89 (5) (2022)
Wenyuan Xiong, Sofia Friberg Hietala, Joakim Nyberg, Orestis Papasouliotis, Andreas Johne, Karin Berghoff, Kosalaram Goteti, Jennifer Dong, Pascal Girard, Karthik Venkatakrishnan, Rainer Strotmann
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations. Cancer chemotherapy and pharmacology 90 (1) (2022)